APM Stock Analysis: Buy, Sell, or Hold?
APM - Aptorum Group Limited Class A Ordinary Shares
$0.84
-0.09 (-9.88%)
▼
5d:
-30.74%
30d:
+7.41%
90d:
-26.48%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 29, 2026
28d
Get Alerted When APM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APM is down 30.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APM is down 30.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APM is currently trading at $0.84, which is considered fair relative to its 30-day fair value range of $0.74 to $0.99.
Technical Outlook: Technically, APM is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $1.34. Short-term momentum is weak, with the stock down 9.9% recently.
Market Sentiment: APM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $80.00 (+9445.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APM is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $1.34. Short-term momentum is weak, with the stock down 9.9% recently.
Market Sentiment: APM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $80.00 (+9445.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.74 -
$0.99
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-9.9%)
- BULLISH: Trading 9445.4% below Wall St target ($80.00)
- WARNING: Recommendation downgraded due to -30.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.74 -
$0.99
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.75
Resistance Level
$1.34
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Wall Street Target
$80.00
(+9445.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: March 30, 2026 10:55 PM ET
Data refreshes hourly during market hours. Next update: 11:55 PM
Data refreshes hourly during market hours. Next update: 11:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 58 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 67 BUY |
